3 February 2021 — Compass, through its M&A advisory arm is pleased to announce that it has served as the sole advisor in the CDC’s strategic investment of EGP1,885 million in Alfa Medical Group (AMG), a leading Egyptian diagnostic and medical care company.

Alfa Medical Group is the largest integrated healthcare provider in Egypt with 140+ diagnostic medical labs, seven radiology centers, as well as 170-bed hospital. The funds will be used to fund the building of new hospitals as well as expansions in the labs and scan business., The Group traces its roots to the El-Safa hospital founded in 1977 by the late Prof. Samir Talaat, followed by Alfa Scan and Alfa Laboratories established over 25 years ago.

CDC Group, the UK’s development finance institution and impact investor, has today announced a EGP1,885 million minority equity investment in AMG alongside healthcare investor Africa Platform Capital, the family office of Simon Rowlands, a leading sector expert with a strong track record in healthcare and former co-founder of the global private equity firm, Cinven, where he led the healthcare team.

“We are pleased to have played a role in this deal which will allow Alfa Medical Group to further expand its business, increase access to medical care and broaden its hospital footprint. This deal is a landmark for the Egyptian healthcare sector and with its closure, Compass Capital has established itself as one of the leading financial advisors in the market”, said Tarek Abdel-Rahman, Compass Capital Managing Partner.


Notes for Editors

Compass is a leading private equity firm focusing on value investing. The firm’s multi-disciplinary team has a long and successful track record of generating attractive investment returns having successfully executed numerous transactions requiring capital flexibility, financial restructuring, and operational turnaround. Compass follows a disciplined investment approach that hinges on defining strategic initiatives, agile implementation of strategy, supporting talented management, and providing required growth capital to drive growth. The company is a principal investor in its own transactions and actively works to ensure that the interests of all stakeholders are aligned in the investments it pursues.



Forward-looking statements:

This communication contains certain forward-looking statements. A forward-looking statement is any statement that does not relate to historical facts and events, and can be identified by the use of such words and phrases as “according to estimates”, “aims”, “anticipates”, “assumes”, “believes”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “is of the opinion”, “may”, “plans”, “potential”, “predicts”, “projects”, “should”, “to the knowledge of”, “will”, “would” or, in each case their negatives or other similar expressions, which are intended to identify a statement as forward-looking. This applies, in particular, to statements containing information on future financial results, plans, or expectations regarding business and management, future growth or profitability and general economic and regulatory conditions and other matters affecting the Company.

Forward-looking statements reflect the current views of the Company’s management (“Management”) on future events, which are based on the assumptions of the Management and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. The occurrence or non-occurrence of an assumption could cause the Company’s actual financial condition and results of operations to differ materially from, or fail to meet expectations expressed or implied by, such forward-looking statements.

The Company’s business is subject to a number of risks and uncertainties that could also cause a forward-looking statement, estimate or prediction to differ materially from those expressed or implied by the forward-looking statements contained in this prospectus. The information, opinions and forward-looking statements contained in this communication speak only as at its date and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this communication.